VANGUARD GROUP INC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 36 filers reported holding REPROS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$486,000
+89.8%
735,447
-8.3%
0.00%
Q3 2017$256,000
-30.1%
801,737
+0.9%
0.00%
Q2 2017$366,000
-65.7%
794,303
-10.7%
0.00%
Q1 2017$1,068,000
-8.3%
889,850
+0.8%
0.00%
Q4 2016$1,165,000
-41.9%
882,436
-8.0%
0.00%
Q3 2016$2,005,000
+24.0%
958,977
-4.5%
0.00%
Q2 2016$1,617,000
+100.9%
1,004,041
+21.1%
0.00%
Q1 2016$805,000
-19.6%
829,431
+0.3%
0.00%
Q4 2015$1,001,000
-82.3%
827,190
+8.4%
0.00%
Q3 2015$5,668,000
+12.7%
762,838
+8.5%
0.00%
Q2 2015$5,029,000
-17.2%
703,287
-0.5%
0.00%
Q1 2015$6,073,000
-6.3%
706,907
+8.7%
0.00%
Q4 2014$6,483,000
-0.5%
650,225
-1.2%
0.00%
-100.0%
Q3 2014$6,513,000
-41.3%
657,860
+2.6%
0.00%0.0%
Q2 2014$11,097,000
+2.7%
641,383
+5.3%
0.00%0.0%
Q1 2014$10,806,000
+3.6%
609,134
+6.9%
0.00%0.0%
Q4 2013$10,427,000
-29.1%
569,763
+3.8%
0.00%0.0%
Q3 2013$14,712,000
+53.2%
548,958
+5.4%
0.00%0.0%
Q2 2013$9,606,000520,6580.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$11,290,0004.00%
SENZAR ASSET MANAGEMENT, LLC 764,406$7,621,0002.23%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$3,280,0000.88%
RTW INVESTMENTS, LP 229,364$2,287,0000.85%
CQS Cayman LP 700,000$6,979,0000.46%
GENERAL AMERICAN INVESTORS CO INC 508,375$5,068,0000.40%
Alden Global Capital Ltd 154,000$1,535,0000.37%
J. Goldman & Co LP 197,500$1,969,0000.23%
Baker Brothers Advisors 2,000,000$19,940,0000.20%
SPHERA FUNDS MANAGEMENT LTD. 100,000$997,0000.17%
View complete list of REPROS THERAPEUTICS INC shareholders